During the past decade, Interventional Cardiology Research, St. Paul's Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Interventional Cardiology Research, St. Paul's Hospital" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Interventional Cardiology Research, St. Paul's Hospital" are "Atherosclerosis" (1 trials) and "Vascular Disease" (1 trials). Many other conditions were trialed in "Interventional Cardiology Research, St. Paul's Hospital" in a lesser frequency.

The vast majority of trials in "Interventional Cardiology Research, St. Paul's Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Interventional Cardiology Research, St. Paul's Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Interventional Cardiology Research, St. Paul's Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Interventional Cardiology Research, St. Paul's Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".